gefitinib has been researched along with cryptotanshinone in 2 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (cryptotanshinone) | Trials (cryptotanshinone) | Recent Studies (post-2010) (cryptotanshinone) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 370 | 0 | 268 |
| Protein | Taxonomy | gefitinib (IC50) | cryptotanshinone (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 90.06 | |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 9.02 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.722 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 10 | |
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | 4.6 | |
| Tryptophan 2,3-dioxygenase | Homo sapiens (human) | 9.8 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 1.47 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 1.47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Han, S; Jia, Q; Lin, Y; Lv, Y | 1 |
| Bai, X; Cai, P; Cao, L; Hong, W; Huang, M; Jin, J; Xu, C; Zhao, Z | 1 |
2 other study(ies) available for gefitinib and cryptotanshinone
| Article | Year |
|---|---|
Dual-mixed/CMC model for screening target components from traditional Chinese medicines simultaneously acting on EGFR & FGFR4 receptors.
Topics: Abietanes; Alkenes; Cell Proliferation; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; ErbB Receptors; Gefitinib; HEK293 Cells; Humans; Phenanthrenes; Polyphenols; Protein Kinase Inhibitors; Receptor, Fibroblast Growth Factor, Type 4; Salvia miltiorrhiza; Sorafenib; Spectrometry, Mass, Electrospray Ionization | 2019 |
Cryptotanshinone strengthens the effect of gefitinib against non-small cell lung cancer through inhibiting transketolase.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Fibroblasts; Gefitinib; Gene Knockdown Techniques; Humans; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; NF-E2-Related Factor 2; Phenanthrenes; Transketolase; Up-Regulation; Xenograft Model Antitumor Assays | 2021 |